IDXXIDEXX Laboratories, Inc.

IDXX Stock Price, Valuation & Chart | IDEXX Laboratories, Inc.

Compare

$556.93+11.07 (+2.03%)

At close · 21 Aug 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Diagnostics & Research IDXX intrinsic value Is IDXX overvalued or undervalued

Overview Financials Dividends Ratios

IDXX Historical price chart

IDXX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization43.93B

PE Ratio39.17

EPS14.22

Trading Volume472.69K

Today's High/Low557.56/545.65

Dividend Yield0.00

52 Week High/Low769.98/518.55

Shares Outstanding78.88M

IDXX Financial Statement

IDXX Analyst ratings

IDXX Analysis & performance metrics

IDXX Company profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water…

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid…

IDXX Management team

Name

Position

Bob Asmann

Senior Vice President of Global Operations

Michael P. Johnson

Executive Vice President & Chief Human Resources Officer

Julie Godon

Senior Vice President & Global Marketing Officer

Andrew EmersonCFO

Executive Vice President, Chief Financial Officer & Treasurer

Nimrata Khatra Hunt P.E., Ph.D.

Executive Vice President of Global Strategy & Commercial

Martin Smith Ph.D.

Executive Vice President of Global Operations and R&D

Sharon E. Underberg J.D.

Executive Vice President, General Counsel, & Corporate Secretary

Jonathan J. MazelskyCEO

President, Chief Executive Officer & Director

Name

Position

Bob Asmann

Senior Vice President of Global Operations

Michael P. Johnson

Executive Vice President & Chief Human Resources Officer

Julie Godon

Senior Vice President & Global Marketing Officer

Andrew EmersonCFO

Executive Vice President, Chief Financial Officer & Treasurer

Nimrata Khatra Hunt P.E., Ph.D.

Executive Vice President of Global Strategy & Commercial

Martin Smith Ph.D.

Executive Vice President of Global Operations and R&D

Sharon E. Underberg J.D.

Executive Vice President, General Counsel, & Corporate Secretary

Jonathan J. MazelskyCEO

President, Chief Executive Officer & Director

Management Team

Bob Asmann

Senior Vice President of Global Operations

Michael P. Johnson

Executive Vice President & Chief Human Resources Officer

Julie Godon

Senior Vice President & Global Marketing Officer

Andrew EmersonCFO

Executive Vice President, Chief Financial Officer & Treasurer

Nimrata Khatra Hunt P.E., Ph.D.

Executive Vice President of Global Strategy & Commercial

Martin Smith Ph.D.

Executive Vice President of Global Operations and R&D

Sharon E. Underberg J.D.

Executive Vice President, General Counsel, & Corporate Secretary

Jonathan J. MazelskyCEO

President, Chief Executive Officer & Director

Management

Bob Asmann

Senior Vice President of Global Operations

Michael P. Johnson

Executive Vice President & Chief Human Resources Officer

Julie Godon

Senior Vice President & Global Marketing Officer

Andrew EmersonCFO

Executive Vice President, Chief Financial Officer & Treasurer

Nimrata Khatra Hunt P.E., Ph.D.

Executive Vice President of Global Strategy & Commercial

Martin Smith Ph.D.

Executive Vice President of Global Operations and R&D

Sharon E. Underberg J.D.

Executive Vice President, General Counsel, & Corporate Secretary

Jonathan J. MazelskyCEO

President, Chief Executive Officer & Director

Total 8 executives

IDXX Frequently asked questions

What is IDEXX Laboratories, Inc. (IDXX) Stock Price?

Current stock price of IDEXX Laboratories, Inc. (IDXX) stock is $556.93. The stock price is +2.03% higher in the session. The intraday range can be seen from this page. Volume of IDEXX Laboratories, Inc. (IDXX) stock is 472.69K.

Last updated at 21 Aug 2026, 08:00 pm.

Why is the IDEXX Laboratories, Inc. (IDXX) stock price going up or down today?

The stock price of IDEXX Laboratories, Inc. (IDXX) can change with earnings, company news, and overall market sentiment. IDEXX Laboratories, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the IDEXX Laboratories, Inc. stock expensive at its current price?

Whether IDEXX Laboratories, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IDXX on this page is 39.17. EPS on this page is 14.22. Compare those figures with peers and growth expectations before deciding if the current IDEXX Laboratories, Inc. price is justified.

How has the stock price of IDEXX Laboratories, Inc. (IDXX) performed historically?

Historical performance for IDEXX Laboratories, Inc. (IDXX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IDXX reacted to past earnings and market events.

Should I buy IDEXX Laboratories, Inc. (IDXX) stock, at this price?

Buying IDEXX Laboratories, Inc. (IDXX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.